EMEA-000977-PIP01-10) - paediatric investigation plan

Dermatophagoides pteronyssinus

Dermatophagoides farinae

Key facts

• Active Substance:
  • Dermatophagoides pteronyssinus
  • Dermatophagoides farinae
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/34/2011
• PIP number:
  EMEA-000977-PIP01-10)
• Pharmaceutical form(s):
  Oral solution
• Condition(s) / indication(s):
  Treatment of allergic rhinitis / rhino-conjunctivitis
• Route(s) of administration:
  Sublingual use
• Contact for public enquiries:

  Stallergenes S.A.

  [e-mail]; France; Phone: [phone]; Fax: [phone]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  28/01/2011

Decision

P/34/2011: EMA decision of 28 January 2011 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for house dust mites allergen extract from Dermatophagoide...

AdoptedReference Number: EMA/58433/2011